- 1.DPP9 inhibition boosts antitumor immunity by disrupting BRISC-mediated PD-L1 expression in clear cell renal cell carcinoma
- 2.Impact of Depression on Efficacy of PD-1/PD-L1 Inhibitors in Non-Small Cell Lung Cancer: A Multicentre, Prospective Trial (STRESS-LUNG-1)
- 3.Prenylated PALM2 Promotes the Migration of Esophageal Squamous Cell Carcinoma Cells through Activating Ezrin
“和元李记”由和元生物 (股票代码:688238) 和李记生物合资成立的,主营“李记生物”“Life-ilab”试剂品牌
返回




